When chronic pain disrupts daily life, finding effective relief often means visiting multiple providers, scheduling separate appointments, and piecing together a fragmented treatment plan. Paun Family ...
Background Amyloid transthyretin (ATTR) amyloidosis is a rare, life-threatening disease frequently manifesting with ...
Doctors and health experts say that our feet is one of the most important part of our body. We have to realise that almost 26 ...
Researchers have found in a new research that HbA1c shows a strong association with the severity of diabetic peripheral ...
Ben Duffin, from Sydney, was enjoying a normal, healthy life with his young family, completely unaware that an unexpected ...
We describe an unusual case of a woman in her 30s who had recently undergone Roux-en-Y gastric bypass and presented to the emergency department with a 6-week history of intractable nausea and vomiting ...
Trodelvy showed fewer severe side effects, such as neutropenia and diarrhea, compared to chemotherapy in untreated TNBC ...
“Sustained exposure of elevated levels of lead poses increased potential toxicological risks to consumers to include ...
Fulgent is set to buy Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to scale lab services.
NEW YORK – Fulgent Genetics announced on Monday that it has entered into a definitive agreement to acquire lab service provider StrataDx, as well as certain assets of Bako Diagnostics. Fulgent said it ...
Fulgent Genetics has signed a definitive agreement to buy specific assets of Bako Diagnostics and to acquire StrataDx, two US ...
Fulgent Genetics will acquire assets from Bako Diagnostics and StrataDx for $55.5 million in a deal that will expand the company's offering of testing services.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback